JPRN-UMIN000006016尚未招募未知
Phase 2 study of combination chemotherapy(VBL/PSL, MTX, 6MP) in patients with primary untreated adult langerhans cell histiocytosis - Combination chemotherapy in patients with primary untreated adult langerhans cell histiocytosis
Department of Hematology, International Medical Center, Saitama Medical University0 个研究点目标入组 5 人开始时间: 2011年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •A patient is uneligible if he (she) has (a) to (m). (a) SaO2 bellow 93% in room air. (b) Serum Cr level above 2.0 mg/dL. (c) T.Bil level above 2.0 mg/dL or GPT over 4 times of upper limit. (d) Uncontrolable DM using insurin. (e) Uncontrolable Hypertention. (f) History of myocardial infarction, congestive heart failure, unstable angina. (g) Resting ejection fraction bellow 50% by UCG. (h) Have an active cancer. (i) On or taking major tranquilizer, antidepressant, antimanic. (j) Uncontrollable active infection. (k) History of adverse reaction for the agents included in the protocol (l) Woman who is pregnant, possibly pregnant or breast feeding. (m) Inadequate for clinical trial entry by the attending physicians.
研究者
相似试验
已完成
2 期
A Phase II study of combination chemotherapy including Bortezomib in pediatric patients with relapsed acute lymphoblastic leukemia (Investigator-initiated clinical trial)A high-risk group of pediatric patients with first relapse of ALLor refractory ALL (patients who develop 2nd or subsequent relapse, relapse after hematopoietic cell transplantation or fail to achieve remission induction with one or more therapies).JPRN-UMIN000023815Department of Pediatric Oncology, National Cancer Center Hospital22
未知
2 期
A phase II study of combination chemotherapy of oral tegafur/uracil, leucovorin and bevacizumab for patients not appropriate for intensive therapy with unresectable or recurrent colorectal cancerunresectable metastatic/recurrent colorectal cancerJPRN-UMIN000024330Dept of Surgical Oncology Osaka City University Graduate School of Medicine35
已完成
2 期
Phase II study of combination chemotherapy in treating pediatric patients with newly diagnosed intracranial germinomaJPRN-UMIN000002397Japanese Pediatric Brain Tumor Consortium50
招募中
2 期
Multicenter phase II study of combination chemotherapy with IRIS and Cetuximab as second line therapy in patient with colorectal cancercolorectal cancerJPRN-UMIN000006793ippon Medical School Musashikosugi Hospital40
已完成
1 期
Phase 1/2 study of triple combination chemotherapy with Carboplatin, nab-Paclitaxel, and Bevacizumab for chemotherapy-naïve stageIIIB/IV non- squamous non-small-cell lung cancer (TORG1424/OLCSG1402)Advanced stage IIIB/IV non-squamous non-small cell lung cancerJPRN-UMIN000014560Thoracic Oncology Research Group55